Drug stocks are trading sluggishly in early activity as Sanofi-Aventis announces that it has commenced a hostile $69 a share bid for Genzyme Corp.
MarketWatch.com - Top Stories, MarketWatch
Mon, 10/04/2010 - 7:37am
Drug stocks are trading sluggishly in early activity as Sanofi-Aventis announces that it has commenced a hostile $69 a share bid for Genzyme Corp.